Susan Hasty, Publisher
Table of Contents . . . February 10th, 1997
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Cardiovascular Gene Transfer - AAV Vector Facilitates Long-Term Myocardium Gene Transfer
HIV Gene Therapy - Clinical Trial to Be Conducted in HIV-1 Discordant Identical Twins
Angiogenesis (Blood Coagulation) - Malignant Tumor Regression Induced by Coagulating Blood Supply
Animal Models - Mice Help Researchers Isolate and Identify Cancer Causes
Associations - American Society of Gene Therapy Formed
Cancer Gene Therapy - Gene Therapists Cautioned to Choose Wild-Type p53 Molecule Carefully
Cancer Gene Therapy - Lung Cancer Patients Complete Phase I Gene Therapy Protocol
Cancer Gene Therapy - Tissue Plasminogen Activator Gene Therapy Effective Against Hepatic Metastasis
Cancer Gene Therapy - Tissue Targeted Therapy for Metastatic Thyroid Carcinoma
Genetics - Protein Responsible for Human DNA Replication Discovered
Industry News (Joint Venture) - Agreement Announced To Improve Genetic Information Management
Industry News (Joint Venture) - Leukemia Ex Vivo Cell Therapy Treatment Partnership Formed
Industry News (Patents and Technology) - Antibody Humanization Technology Patent Allowance Received
Industry News (Patents and Technology) - Patent Received on DNA Amplification Technology
Antisense Therapy - "Ribozymes as Inhibitors of Gene Function."
Antisense Therapy (Hepatitis) - "External Guide Sequences (EGSs) - Harnessing the Ribozyme RNase P to Develop Therapeutics."
Cancer Gene Therapy - "Tumor Destruction by Complement Lysis After Retroviral Transfer and Expression of the (alpha)-1,3 Galactosyl Transferase Gene."
Cancer Gene Therapy (Suicide) - "Effects of HSV-tk and IL-4 Gene Transfer in Experimental Gliomas."
Gene Transfer (Stem Cells) - "High Efficiency Adenovirus-Mediated Gene Transfer into Human CD34+ Hematopoietic Cells."
Gene Transfer (mdr1) - "Construction of Retroviral Vectors Containing Human Multidrug Resistance Gene (mdr1) and their Expression in NIH3T3 Cells."
Vaccine Development (Hepatitis) - "Comparison Between Hepatitis B Surface Antigen (HBsAg) Particles Derived from Mammalian (CHO) Cells (CHO-HBsAg) and from Yeast (Hansenula polymorp
Antisense Technology - "2'-O-Aminopropyl Ribonucleotides: A Zwitterionic Modification That Enhances the Exonuclease Resistance and Biological Activity of Antisense Oligonucleotides."
Antisense Technology - "Cationic Lipids Reduce Time and Dose of c-myc Antisense Oligodeoxynucleotides Required to Specifically Inhibit Burkitt's Lymphoma Cell Growth."
Antisense Technology - "Inhibition of Cytochrome P450 1A1 by Antisense Phosphorothioate Oligonucleotide in Hepa 1c1c7 Cells."
Cancer Gene Therapy - "Gene Therapy for Cancer: What Have We Done and Where Are We Going?"
Cancer Gene Therapy - "Gene Therapy for Malignant Neoplasms of the CNS."
Cancer Gene Therapy - "Genetically Modified Tumour Vaccines: Insertion of the IL-2 Gene Downregulates Tumorigenicity More Efficiently Than Insertion of the CD80 Gene."
Cancer Gene Therapy - "Inhibition of Peritoneal Dissemination of Colon Carcinoma in Syngeneic Mice Immunized with Interleukin-2-Producing Cells."
Cancer Gene Therapy - "Method for Concentrating and Purifying Recombinant Autonomous Parvovirus Vectors Designed for Tumour-Cell-Targeted Gene Therapy."
Cancer Gene Therapy - "The 12-Lipoxygenase Gene-Transfected MCF-7 Human Breast Cancer Cell Line Exhibits Estrogen-Independent, But Estrogen and Omega-6 Fatty Acid-Stimulated Proliferation in vitro COM
Cancer Gene Therapy - "Transduction of Murine and Human Tumors using Recombinant Adenovirus Vectors."
HIV Gene Therapy - "Replication of Primary HIV-1 Isolates Is Inhibited in PM1 Cells Expressing sCD4-KDEL."
Hematology - "Gene Therapy for Hematopoietic and Immune Disorders."
Leukemia - "Adenovirus Vector Infection of Chronic Lymphocytic Leukemia B Cells."
Neuroscience - "Neural Toxicity of Retroviruses."
Ocular - "In vivo Gene Transfer into the Retina Mediated by a Novel Liposome System."
Ribozymes - "Anti-Gene Therapy: The Use of Ribozymes to Inhibit Gene Function."
Vector Development - "Inducible Retroviral Vectors Regulated by lac Repressor in Mammalian Cells."
Vector Development - "Non-Viral Gene Delivery Systems."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.